Home | | Modern Pharmacology with Clinical Applications | Cardiac Electrophysiology: Triggered Activity

Cardiac Electrophysiology: Triggered Activity - | Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail |

Chapter: Modern Pharmacology with Clinical Applications: Pharmacological Management of Chronic Heart Failure

Cardiac Electrophysiology: Triggered Activity

Triggered activity occurs when after-depolarizations in-duced by a preceding action potential raise the resting membrane potential above the threshold value, leading to an additional action potential.

Triggered Activity

Triggered activity occurs when after-depolarizations in-duced by a preceding action potential raise the resting membrane potential above the threshold value, leading to an additional action potential. After-depolarizations may be categorized as early, occurring during phase III of the action potential before achieving full repolarization, or delayed, occurring after full repolarization of the membrane. After-depolarizations may stimulate an iso-lated extrapropagated impulse or lead to sustained repet-itive activity. The crucial difference between triggered ac-tivity and abnormal automaticity is that triggered activity depends on a preceding action potential and cannot be self-induced. After-depolarizations or triggered activity are often associated with excessive increases in intracel-lular [Ca ]. The potential for development of triggered activity is accentuated in the presence of an increase in extracellular [Ca ] that would increase the amount of ionized calcium entering the cell during depolarization. Furthermore, conditions or pharmacological interven-tions favoring prolongation of the plateau (phase 3) of the action potential and prolongation of the QT interval of the electrocardiogram would increase intracellular [Ca++ ] and the potential for proarrhythmia.

Early after-depolarizations are purported to be the mechanism giving rise to torsades de pointes. Conditions or drugs known to prolong the action potential, espe-cially by interventions that decrease the outward potas-sium currents, facilitate development of torsades de pointes tachyarrhythmias. Early after-depolarizations may develop in association with hypokalemia, hypoxia, acidosis, and a wide range of pharmacological agents that interfere with outward currents or enhance inward currents. Antiarrhythmic agents, in particular sotalol, quinidine, and dofetilide, may give rise to after-depolar-izations and torsades de pointes tachyarrhythmia in persons with underlying cardiac abnormalities or alter-ations in plasma electrolytes. Conditions leading to bradycardia also may facilitate development of torsades de pointes tachyarrhythmia.

Early after-depolarizations and the associated ven-tricular arrhythmia can be prevented or suppressed by the appropriate adjustment of plasma potassium and/or magnesium concentrations. Lidocaine or procainamide may be effective for termination of the arrhythmia.


Delayed after-depolarizations (Figure 16.4) may oc-cur in the presence of a rapid heart rate, digitalis glyco-sides, hypokalemia, hypercalcemia and catecholamines. Each of these influences ultimately leads to an increase in intracellular ionized calcium that is known to activate an inward ionic current. The inward ionic current acti-vates a nonselective channel that normally is involved with the transport of sodium but that under pathophys-iological conditions may permit the movement of sodium or potassium ions. Upon reaching threshold, the calcium-induced oscillatory potentials lead to the pro-duction of a sustained ventricular arrhythmia. Delayed after-depolarizations, in contrast to early after-depolar-izations, are more likely to produce triggered tachy-arrhythmias during periods of short pacing cycle lengths (rapid heart rates). Exercise-induced ventricular tachy-cardia in persons without overt cardiac disease exem-plifies such a situation. The electrophysiological abnor-mality is catecholamine dependent and calcium sensitive. The arrhythmia may respond to L-type cal-cium channel antagonists or inhibitors of the cardiac β-adrenoceptor. Each of these approaches would serve to reduce the tissue calcium concentration.

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved S21. Developed by Therithal info, Chennai.